[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100624339":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":25,"centralContacts":29,"locations":39,"responsibleParty":60,"collaborators":18,"id":62,"slug":63,"hasResults":64,"nctId":65,"briefTitle":66,"officialTitle":67,"acronym":18,"eligibilityCriteria":68,"healthyVolunteers":64,"sex":69,"minAge":70,"maxAge":71,"enrollmentInfo":72,"targetDuration":18,"studyType":75,"phases":76,"briefSummary":78,"conditions":79,"keywords":18,"overallStatus":42,"whyStopped":18,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":82,"startDateStruct":85,"completionDateStruct":87,"leadSponsor":89,"locationsCount":90},{"fullName":5,"class":6},"Baskent University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Intervention","EXPERIMENTAL","In the first phase, all participants will complete a Sociodemographic Data Form. The State-Trait Anxiety Inventory and FACT-G will be applied as pre- and post-tests during each of the three chemotherapy sessions. The MASCC Antiemesis Tool will be administered after the 1st session and before\u002Fafter the 2nd and 3rd sessions. Participants will also self-complete the MASCC scale and a nausea-vomiting diary for seven days after each cycle. On day 7, the FACT-G will be administered via phone to evaluate changes in functional and emotional status.",[13],"Behavioral: guided imagery",{"label":15,"type":16,"description":17,"interventionNames":18},"control","NO_INTERVENTION","In each chemotherapy cycle (1st, 2nd, and 3rd), control group patients will complete the Sociodemographic Form and State-Trait Anxiety Inventory before treatment, and State-Trait Anxiety Inventory again post-treatment. They will receive the MASCC Antiemesis Scale and a nausea\u002Fvomiting diary to complete daily for 7 days. On day 7, the FACT-G and a telephone follow-up form will be administered via phone. This standardized procedure will be repeated in all three cycles to ensure consistent data collection.",null,[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":18},"BEHAVIORAL","guided imagery","Guided imagery is a method of mind-body communication, fundamentally defined as a flow of thoughts involving what we smell, taste, see, hear, and touch, or as the way our mind encodes, stores, and retrieves information. It is based on the understanding that the body and mind are interconnected and that the mind can influence the body. Stress and anxiety directly affect the brain and immune system",[9],[26],{"name":27,"affiliation":5,"role":28},"Hatice Kübra YURDAKUL, Msc","STUDY_DIRECTOR",[30,35],{"name":27,"role":31,"phone":32,"phoneExt":33,"email":34},"CONTACT","0312 246 66 66","2078","kubraoz86@hotmail.com",{"name":36,"role":31,"phone":32,"phoneExt":37,"email":38},"Cansu Akdag Topal, PhD","6675","cansua05@gmail.com",[40,56],{"facility":41,"status":42,"city":43,"state":18,"zip":44,"country":45,"countryCode":18,"cosmosGeoPoint":46,"geoPoint":51,"contacts":52},"Başkent University","RECRUITING","Ankara","06790","Turkey (Türkiye)",{"type":47,"coordinates":48},"Point",[49,50],32.85427,39.91987,{"lat":50,"lon":49},[53],{"name":54,"role":31,"phone":55,"phoneExt":18,"email":38},"Cansu Akdag Topal","05545386987",{"facility":41,"status":42,"city":43,"state":18,"zip":18,"country":45,"countryCode":18,"cosmosGeoPoint":57,"geoPoint":59,"contacts":18},{"type":47,"coordinates":58},[49,50],{"lat":50,"lon":49},{"type":61,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR","100624339","guided-imagery-of-the-gynecological-cancer-100624339",false,"NCT07408349","Guided Imagery of the Gynecological Cancer","The Effect of Guided Imagery on Nausea, Vomiting, Anxiety and Quality of Life in Gynecologic Cancer Patients Undergoing Chemotherapy: A Randomized Controlled Trial","Inclusion Criteria:\n\n* Having a diagnosis of another type of cancer\n* An ECOG (Eastern Cooperative Oncology Group) performance score of ≥3 (PS 3: Confined to bed for more than half of the day, limited self-care; PS 4: Completely bedridden, unable to perform self-care)\n\nExclusion Criteria:\n\n* Choosing to withdraw from the study\n* Refusing to practice guided imagery before chemotherapy treatment","FEMALE","18 Years","90 Years",{"count":73,"type":74},46,"ESTIMATED","INTERVENTIONAL",[77],"NA","The goal of this randomized controlled trial is to evaluate the effectiveness of a guided imagery intervention in women receiving chemotherapy for gynecological cancers at Başkent University Ankara Hospital Outpatient Chemotherapy Unit.\n\nThe main questions it aims to answer are:\n\nDoes guided imagery improve psychological or physical outcomes during chemotherapy? How do outcomes differ between the intervention (guided imagery) and control (standard information) groups?\n\nResearchers will compare both groups to assess the effect of guided imagery across three repeated measurements.\n\nParticipants will:\n\n* Be randomly assigned (1:1) to intervention or control groups via an online randomization tool.\n* Complete outcome assessments at three time points.\n* Be part of a sample of 158 women (minimum 76 per group), based on power analysis for repeated measures ANOVA (effect size f = 0.25, 95% power, 95% confidence).\n\nThe study will follow the CONSORT-Outcomes 2022 guideline and be registered at ClinicalTrials.gov.",[80],"Gynecologic Cancer","2026-02-10",{"date":83,"type":84},"2026-02-13","ACTUAL",{"date":86,"type":84},"2026-01-19",{"date":88,"type":74},"2026-12-31",{"name":5,"class":6},2]